Terry Kim - Access Bio Chief Africa

950130 Stock  KRW 5,540  170.00  2.98%   

Insider

Terry Kim is Chief Africa of Access Bio
Phone732 873 4040
Webhttp://www.accessbiodiagnostics.net

Access Bio Management Efficiency

The company has return on total asset (ROA) of 0.3467 % which means that it generated a profit of $0.3467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 108.0209 %, meaning that it generated $108.0209 on every $100 dollars invested by stockholders. Access Bio's management efficiency ratios could be used to measure how well Access Bio manages its routine affairs as well as how well it operates its assets and liabilities.
Access Bio has accumulated 10.13 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. Access Bio has a current ratio of 16.15, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Access Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Access Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Access Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Access to invest in growth at high rates of return. When we think about Access Bio's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

ChongOh AnPolaris Office Corp
50
JinHong ParkBarunson Entertainment Arts
52
KwanHee KangPolaris Office Corp
71
Tom BuhlKaonmedia Co
N/A
KyungNam KimPolaris Office Corp
56
MyungSe KimPolaris Office Corp
80
DongSuk KimPolaris Office Corp
62
JinKwon JungPolaris Office Corp
58
KwangHo ChoiBarunson Entertainment Arts
N/A
JongWoon ParkBarunson Entertainment Arts
N/A
YoungSoo KwakPolaris Office Corp
77
TaeBong ChoiKaonmedia Co
63
ChulMin KimKaonmedia Co
59
TaeWon KimKaonmedia Co
54
SungYeon WonBarunson Entertainment Arts
N/A
SeungHo LeeBarunson Entertainment Arts
N/A
SunWoo JungBarunson Entertainment Arts
N/A
ByungTak YooPolaris Office Corp
49
KwangHo AhnBarunson Entertainment Arts
N/A
IlBoo KimSangsin Energy Display
73
WonYong ChungKaonmedia Co
53
Access Bio, Inc. researches, develops, and manufactures in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products. Access Bio (950130) is traded on KOSDAQ in Korea and employs 69 people.

Management Performance

Access Bio Leadership Team

Elected by the shareholders, the Access Bio's board of directors comprises two types of representatives: Access Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Access. The board's role is to monitor Access Bio's management team and ensure that shareholders' interests are well served. Access Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Access Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Andrew Gorman, B Board
Terry Kim, Chief Africa
Philip CPA, Treasurer Board
John Kim, Managing Partner
N MD, Clinical Board
YoungHo Choi, CEO Pres
Janet Strong, DODG Board

Access Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Access Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Access Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Access Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Access Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Access Stock

  0.62228670 Ray CoPairCorr
  0.84263690 DRGEMPairCorr

Moving against Access Stock

  0.54105560 KB Financial GroupPairCorr
The ability to find closely correlated positions to Access Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Access Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Access Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Access Bio to buy it.
The correlation of Access Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Access Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Access Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Access Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Access Stock

Access Bio financial ratios help investors to determine whether Access Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Access with respect to the benefits of owning Access Bio security.